Showing results (361-370 of 379) with videos related to

Sort By:
Pageof 38
Nature Immunology|May 29, 2023
Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbiditiesWuji Zhang, Lukasz Kedzierski, Brendon Y Chua, et al.
JAMA|February 12, 2020
Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical TrialSteven Y C Tong, David C Lye, Dafna Yahav, et al.
Nature Communications|April 2, 2021
Systems serology detects functionally distinct coronavirus antibody features in children and elderlyKevin J Selva, Carolien E van de Sandt, Melissa M Lemke, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 16, 2024
SARS-CoV-2-specific CD8+ T cells from people with long COVID establish and maintain effector phenotype and key TCR signatures over 2 yearsLouise C Rowntree, Jennifer Audsley, Lilith F Allen, et al.
Cell Reports. Medicine|February 10, 2021
Integrated immune dynamics define correlates of COVID-19 severity and antibody responsesMarios Koutsakos, Louise C Rowntree, Luca Hensen, et al.
JCI Insight|April 10, 2023
Immune profiling of SARS-CoV-2 infection during pregnancy reveals NK cell and γδ T cell perturbationsJennifer R Habel, Brendon Y Chua, Lukasz Kedzierski, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2025
HLA-B*15:01-positive severe COVID-19 patients lack CD8+ T cell pools with highly expanded public clonotypesLouise C Rowntree, Lilith F Allen, Ruth R Hagen, et al.
The New England Journal of Medicine|February 25, 2021
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19, Anthony C Gordon, Paul R Mouncey, et al.
JAMA|March 22, 2022
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial, Charlotte A Bradbury, Patrick R Lawler, et al.
Thorax|May 13, 2025
Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trialLennie Derde, Anthony C Gordon, Paul R Mouncey, et al.
Pageof 38